Immunomodulatory activity of curcumin-entrapped poly d,l-lactic-co-glycolic acid nanoparticles in mice

다국어 초록 (Multilingual Abstract)

Background: Studies have shown that curcumin from Curcuma longa has a wide range of medicinal and immunomodulatory properties. These activities have, however, been hindered by its low bioavailability. Meanwhile, incorporation of nanoparticles has been shown to increase bioavailability of certain drugs. This study was, therefore, conducted to comparatively evaluate the immunomodulatory activity of free and nanoparticulate curcumin in mice.
Methods: Healthy albino mice were sensitized with sheep red blood cells (SRBCs) and thereafter free and nanoparticulate curcumin were administered orally at doses of 5 mg/kg/day and 10 mg/kg/day for 10 days to the mice. The assessment of the immunomodulatory activity was carried out by determining the humoral and cell-mediated immune responses using hemagglutination and delayed-type hypersensitivity assays, respectively. Hematological components and some lymphoid organs of treated mice were further evaluated.
Results: The study showed that nanoparticulate curcumin stimulated higher early cell-mediated immune response at 5 mg/kg and 10 mg/kg when compared to control. While nanoparticulate curcumin significantly stimulated primary humoral immune response with 9.00 ± 1.00 antibody titre (p < 0.05), the free curcumin suppressed the immunity with 3.33 ± 0.67 antibody titre when compared to control. Similar result was observed with secondary humoral antibody titres. Production of white blood cells and weight of the lymphoid organs were also enhanced in the groups that received 10 mg/kg nanocurcumin.
Conclusion: This work showed that poly d,l-lactic-co-glycolic acid entrapped curcumin nanoparticle could increase bioavailability of curcumin for improved immunity.

참고문헌 (Reference)

1 Mimche PN, "The plant basedimmunomodulatory curcumin as a potential candidate forthe development of an adjunctive therapy for cerebralmalaria" 10 : S10-, 2011

2 Waldmann H., "The new immunosuppression" 7 : 476-480, 2003

3 Duan J, "Synthesisand in vitro/in vivo anti-cancer evaluation ofcurcumin ofcurcumin-loaded chitosan/poly (butyl cyanoacrylate)nanoparticles" 400 : 211-220, 2010

4 Goel A, "Specific inhibition ofcyclooxygenase-2 (COX-2) expression by dietary curcumin inHT-29 human colon cancer cells" 172 : 111-118, 2001

5 Tonnesen HH, "Solubility, chemical and photochemicalstability of curcumin in surfactant solutions. Studies ofcurcumin and curcuminoids, XXVIII" 57 : 820-824, 2002

6 Doherty NS, "Selective effects of immunosuppressive agentsagainst the delayed hypersensitivity response and humoralresponse to sheep red blood cells in mice" 11 : 237-242, 1981

7 Kumar V, "Robbins & Cotran pathologicbasis of disease" Saunders 2004

8 Hussain A, "Protectiveeffects of Picrorhiza kurroa on cyclophosphamide-inducedimmunosuppression in mice" 5 : 30-35, 2013

9 Visioli F, "Polyphenols and human health : aprospectus" 51 : 524-546, 2011

10 Bisht S, "Polymeric nanoparticle-encapsulated curcumin("nanocurcumin") : a novel strategy for human cancertherapy" 5 : 1-18, 2007

11 Silva AL, "PLGAparticulate delivery systems for subunit vaccines: linkingparticle properties to immunogenicity" 12 : 1056-1069, 2016

12 Manolova V, "Nanoparticles target distinct dendritic cellpopulations according to their size" 38 : 1404-1413, 2008

13 Ali M, "Nanocurcumin: anovel antifilarial agent with DNA topoisomerase II inhibitoryactivity" 22 : 395-407, 2014

14 Lai JJ, "Monocyte/macrophage androgen receptor suppressescutaneous wound healing in mice by enhancing localTNF-alpha expression" 119 : 3739-3751, 2009

15 Kalish RS, "Molecular mechanisms of CD8+Tcell-mediated delayed hypersensitivity: implications for allergies, asthma and automimmunity" 103 : 192-199, 1999

16 Mazumder AC, "Isolation and identification of Newcastledisease viruses from field outbreaks in chickens andpigeons" 41-48, 2014

17 Ahirwal L, "In vivo immunomodulatory effects of the methanolic leafextract of Gymnema sylvestre in Swiss albino mice" 67 : 561-570, 2015

18 Srivastava RM, "Immunomodulatory and therapeutic activity of curcumin" 11 : 331-341, 2011

19 Verma A, "Immunomodulatory activity ofalcoholic extract of Habenaria intermedia in mice" 5 : 406-409, 2013

20 Eze CO, "Immunomodulatory activities of methanol extract of thewhole aerial part of Phyllantus niruri L" 6 : 41-46, 2014

21 Agarwal SS, "Immunomodulators: a review ofstudies on Indian medicinal plants and synthetic peptides.Part 1: Medicinal plants" B65 : 179-204, 1999

22 Sainis KB, "Immunomodulation" Narosa Publishing House 95-, 1997

23 Lange AM, "IL-4-and IL-5-dependent protective immunity to Onchocercavolvulus infective larvae in BALB/cBYJ mice" 153 : 205-211, 1994

24 Arshami J, "Hypolipidemicand antioxidative effects of curcumin on blood parameters,humoral immunity, and jejunum histology in Hy-line hens" 3 : 178-185, 2012

25 Yallapu MM, "Fabrication ofcurcumin encapsulated PLGA nanoparticles for improvedtherapeutic effects in metastatic cancer cells" 351 : 19-29, 2010

26 Yadav P, "Experimental studies on immunomodulatory potential ofCissus quadrangularis Linn" 2 : 49-53, 2014

27 Sibi PI, "Evaluation of in vivo immunomodulatoryactivity of Punica granatum Linn" 5 : 175-178, 2014

28 Hanh Thuy Nguyen, "Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles" 대한약학회 38 (38): 716-724, 2015

29 Rajakrishnan V, "Effectof curcumin on ethanol-induced stress on mononuclearcells" 16 : 171-173, 2002

30 Weisberg SP, "Dietary curcuminsignificantly improves obesity-associated inflammation anddiabetes in mouse models of diabesity" 149 : 3549-3558, 2008

31 Allen IC, "Delayed-type hypersensitivity models in mice" 1031 : 101-107, 2013

32 Basnet P, "Curcumn : an anti-inflammatorymolecule from a curry spice on the path to cancertreatment" 16 : 4567-4598, 2010

33 Hatcher H, "Curcumin: from ancient medicine to currentclinical trials" 65 : 1631-1652, 2008

34 Luz PP, "Curcumin-loaded into PLGAnanoparticles : preparation and in vitro schistosomicidalactivity" 351 : 593-598, 2012

35 Giri RK, "Curcumin, the activeconstituent of turmeric, inhibits amyloid peptide-inducedcytochemokine gene expression and CCR5-mediatedchemotaxis of THP-1 monocytes by modulating early growthresponse-1 transcription factor" 91 : 1199-1210, 2004

36 Teiten MH, "Curcumin – theparadigm of a multi-target natural compound withapplications in cancer prevention and treatment" 2 : 128-162, 2010

37 Bar-Sela G, "Curcumin as ananti-cancer agent: review of the gap between basic andclinical applications" 17 : 190-197, 2010

38 Wilken R, "Curcumin : a review of anti-cancer properties andtherapeutic activity in head and neck squamous cellcarcinoma" 10 : 12-, 2011

39 Clinical Trial (CTG)., "ClinicalTrials.gov: current clinical trials oncurcumin"

40 Gullett NP, "Cancer preventionwith natural compounds" 37 : 258-281, 2010

41 Singh S, "Biological effects of curcumin and its role incancer chemoprevention and therapy" 6 : 259-270, 2006

42 Basaran AA, "Basaran N.Immunmodulatory activities of some Turkish medicinalplants" 11 : 609-611, 1997

43 Sachdeva H, "Asparagus racemosusameliorates cisplatin induced toxicities and augments itsantileishmanial activity by immunomodulation in vivo" 63 : 21-30, 2014

44 Zulaikha A. Busari, "Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles" Frontiers Media SA 8 : 2017

45 Jurenka JS., "Anti-inflammatory properties of curcumin, amajor constituent of Curcuma longa: a review of preclinicaland clinical research" 14 : 141-153, 2009

46 Xie L, "Amelioration of experimental autoimmuneencephalomyelitis by curcumin treatment throughinhibition of IL-17 production" 9 : 575-581, 2009

47 Badway JA, "Active oxygen species andfunctions of phagocytic leukocytes" 49 : 695-726, 1980